Building on a model of endogenous innovation à la Romer, we analyze the link between legal institutions, innovation and growth. As in Anderlini, Felli and Riboni (2007), we suppose that law-makers are benevolent and we compare two legal systems: a rigid system, where an uncontingent law is written in a statute ex ante (that is, before knowing the state of the technology that will take place) an...

Many criteria have been presented so far for innovation measurement. Presenting the relation between input and output of innovation, completing other criteria and achieving more comprehensive criteria has also been raised. What is of vital importance is the right utilization of these criteria towards measuring innovation. This paper seeks to present a model to measure innovation that, in additi...

biogenerics production has been done in lots of advanced industrial countries since last decades and its legal aspects are adequately addressed. on the other hand, the need of our country to these drugs is inevitable and its production in recent years has begun without taking its legal aspects into account. we don’t have any legal system to regulate biogenerics production and commercialize them...

Commercial insurance companies' have the market incentives and the ability to take on a new role as controllers of rising health care costs. This Note will discuss the market for insurer-directed cost containment, the types of cost control alternatives that could be utilized and the legal restraints on insurer innovation. The analysis of the legal setting for insurer innovation in cost control ...

Using panel data method, this study examines the effects of different dimensions of social capital on innovation at the societal level across 21 countries (19 Asian countries plus Russia and Egypt) for the period 1995-2011. Dimensions of social capital that have been considered in this study include generalized trust, trust toward friends, institutional trust, civic participation, and norms of ...